Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease. (Q35977542)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

Jesus Maria Hernandez Rivas

28 October 2019

author

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Marcos González Díaz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Jesús San Miguel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

R García

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M D Caballero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

J Galende

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M C del Cañizo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

L Vázquez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

English

0 references

publication date

1 December 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

1227-1231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bjc.1993.509

28 October 2019

exact match

0 references

cites work

Hodgkin's disease: biology, treatment, prognosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin's disease: an analysis of 271 non-laparotomised cases (BNLI report no. 22).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

Report of the Committee on Hodgkin's Disease Staging Classification

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

Twenty years of MOPP therapy for Hodgkin's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

Treatment strategies for Hodgkin's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

Prognostic factors in Hodgkin's disease stage IV.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

Autologous bone marrow transplantation for refractory or relapsed Hodgkin's disease: the Memorial Sloan-Kettering Cancer Center experience using high-dose chemotherapy with or without hyperfractionated accelerated total lymphoid irradiation.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

The prognostic significance of mediastinal bulk in patients with stage IA-IVB Hodgkin's disease: a report from the Manchester Lymphoma Group.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

Prognostic factors for Stage IV Hodgkin's disease treated with MOPP, with or without bleomycin

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968658

Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation

24 September 2018

1 reference

12 December 2020

Clinical features and response to treatment of infradiaphragmatic Hodgkin's disease

1 reference

12 December 2020

The second chance for advanced Hodgkin's disease

1 reference

12 December 2020

1 reference

12 December 2020

Prognostic significance of serum lactate dehydrogenase in malignant lymphoma

1 reference

12 December 2020

Prognostic factors in pathologic stage III Hodgkin's disease

1 reference

12 December 2020

Prognostic factors in Hodgkin's disease with special reference to age

1 reference

12 December 2020

A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy

1 reference

12 December 2020

Prognostic significance of erythrocyte sedimentation rate in clinical stages I-II of Hodgkin's disease

1 reference

12 December 2020

Pretreatment hematocrit as an independent prognostic variable in Hodgkin's disease

1 reference

12 December 2020

Predictive model for prognosis in advanced diffuse histiocytic lymphoma

1 reference

12 December 2020

Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy

1 reference

12 December 2020

Subdiaphragmatic Hodgkin's disease: laparotomy and treatment results in 49 patients

1 reference

12 December 2020

Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.509

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260377%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference